These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33919778)

  • 1. Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges.
    Kong L; Birkeland AC
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
    Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
    J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor DNA: an emerging biomarker in head and neck cancer.
    Bellairs JA; Hasina R; Agrawal N
    Cancer Metastasis Rev; 2017 Sep; 36(3):515-523. PubMed ID: 28801876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
    Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.
    Mishra V; Singh A; Chen X; Rosenberg AJ; Pearson AT; Zhavoronkov A; Savage PA; Lingen MW; Agrawal N; Izumchenko E
    Br J Cancer; 2022 Feb; 126(3):361-370. PubMed ID: 34876674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Promise of Circulating Tumor DNA in Head and Neck Cancer.
    Aulakh SS; Silverman DA; Young K; Dennis SK; Birkeland AC
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.
    Brandt A; Thiele B; Schultheiß C; Daetwyler E; Binder M
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck.
    Iacob R; Mandea M; Iacob S; Pietrosanu C; Paul D; Hainarosie R; Gheorghe C
    Front Med (Lausanne); 2022; 9():827297. PubMed ID: 35572996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes: Potential Biomarkers and Functions in Head and Neck Squamous Cell Carcinoma.
    Li T; Li J; Wang H; Zhao J; Yan M; He H; Yu S
    Front Mol Biosci; 2022; 9():881794. PubMed ID: 35775082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
    Ebnoether E; Muller L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exosomes: potential liquid biopsy in head and neck cancer].
    Theodoraki MN; Ludwig S
    HNO; 2020 Feb; 68(2):106-110. PubMed ID: 31915880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma.
    Chan JYK; Zhen G; Agrawal N
    Semin Cancer Biol; 2019 Apr; 55():1-7. PubMed ID: 30082187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck cancer: Current challenges and future perspectives.
    Bhat GR; Hyole RG; Li J
    Adv Cancer Res; 2021; 152():67-102. PubMed ID: 34353444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
    Galot R; Machiels JH
    Cancer Treat Rev; 2020 Apr; 85():101992. PubMed ID: 32092618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of a liquid biopsy for head and neck cancers.
    Schmidt H; Kulasinghe A; Kenny L; Punyadeera C
    Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma and Its Therapeutic Prospect.
    Zhang Y; Sun X
    Onco Targets Ther; 2020; 13():10207-10220. PubMed ID: 33116602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges.
    Chantre-Justino M; Alves G; Delmonico L
    Explor Target Antitumor Ther; 2022; 3(4):533-552. PubMed ID: 36071985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A liquid biopsy for head and neck cancers.
    Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
    Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids - the state of art.
    Ribeiro IP; de Melo JB; Carreira IM
    Mol Cytogenet; 2019; 12():33. PubMed ID: 31333762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.